Coronary revascularization

 Dates: September 17-19, 2018

Venue: Bratislava hotel

Ukraine, Kiev

 

Online registration is required.No admission without registration confirmation.

nbscience

(deadline – March 20, 2017)

 

 

Main topics:

 Strategies for pre-intervention diagnosis and imlaging
Detection of coronary artery disease
Detection of ischaemia
Hybrid/combined imaging
Invasive tests
Prognostic value
Detection of myocardial viability
Revascularization for stabe CAD
Evidence basis for revascularisation
Impact of ischaemia burden on prognosis
Optimal medical therapy vs PCI
PCI with drug-eluting stents vs bare metal stents
Coronary artery bypass grafting vs medical therapy
PCI vs coronary artery bypass grafting
Recommendations
Revascularization in non-ST-segment elevation ACS
Intended early invasive or conservative strategies
Risk stratification
Timing of angiography & intervention
Coronary angiography, PCI, & coronary artery bypass grafting
Patient subgroups
Revascularisation in St-segment elevation myoacardial infraction
Reperfusion strategies
Cardiogenic shock and mechanical complications
Special conditions
Diabetes
Myocardial revascularization in patients with chronic kidney disease
Myocardial revascularisation in patients requiring valve surgery
Associated carotid/peripheral arterial disease
Myocardial revascularisation in CHF
Crossed revascularisation procedures
Arrhythmias in patients with ischaemic heart disease
Procedural aspects of coronary artery bypass grafting
Pre-operative management
Surgical procedures
Early post-operative risk
Procedural aspects of PCI
Impact of clinical presentation
Specific lesion subsets
Drug-eluting stents
Adjunctive invasive diagnostic tools
Antithrombotic pharmacotherapy
Elective PCI
Non-St-segment elevation ACS
ST-segment elevation myoacardial infraction
Points of interest and special conditions
Secondary prevention
Background and rationale
Modalities
Settings

Call for Poster Abstracts: 

Important dates:

Abstract submission deadline: March 20, 2017

Acceptance notification: March 22, 2017

The Scientific Program Committee invites you to submit your research in the form of a one-page abstract (2500 characters) . We welcome scholarly research-based submissions .  Case study abstracts will also be welcomed.

Abstracts should include unpublished material and data. Material that has been formally published by the abstract submission dates will not be accepted. Most abstracts without data to support findings will be rejected. However, abstracts that describe study design and methods for well-developed and/or funded studies (i.e., no abstracts for pilot or preliminary studies) may be considered for poster presentation depending on abstract quality.

All abstracts will be anonymously peer reviewed, scored and chosen on merit for poster presentation.

Individuals whose abstract are selected will be required to register for the meeting; abstracts from authors who do not register will not be accepted.

 

 Conditions of participation for participants:

Registration Package   includes  simultaneous translation from Russian to English language , certificate of participation (English language) ,participation in scientific sessions, conference materialsvisit to the exhibition and 10-30% discount for accomodation in hotel.

 

nbscience

(deadline – March 20, 2017)

 

 

Flights:

tickets ukraine

From Europe to Russia from 50 Euros ( one way) : http://wizzair.com/?language=EN

Questions

Contact NBScience’s

Education/Conference Department:

 

conference@nbscience.com

pharmacology

AllConferences.com Directory of Conferences, conventions, exhibits, seminars, workshops, events, trade shows and business meetings. Includes calendar, dates, location, web site, contact and registration information.

stem cell therapy